Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New birth control shot shows promise in early trial

NCT ID NCT04143659

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 22 times

Summary

This early-stage study tests a new long-acting birth control shot called levonorgestrel butanoate in 136 healthy women aged 18-40. The goal is to see how the body processes the drug and how well it prevents ovulation. Researchers will measure hormone levels and use ultrasound to check ovarian activity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY WOMEN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Boston Medical Center Corporation

    Boston, Massachusetts, 02118, United States

  • Columbia University

    New York, New York, 10032, United States

  • Comprehensive Women's Health Center

    Denver, Colorado, 80230, United States

  • Eastern Virginia Medical School

    Norfolk, Virginia, 23507, United States

  • Oregon Health and Science University

    Portland, Oregon, 97239, United States

  • University of California, Davis

    Davis, California, 95817, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

Conditions

Explore the condition pages connected to this study.